Europe Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity

You are here: 麻豆原创 Catalog Pharma & Healthcare Pharmaceutical Manufacturing

Europe Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity

麻豆原创 Research Report Summary

Europe Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity report is published on March 30, 2021 and has 131 pages in it. This market research report provides information about Pharmaceutical Manufacturing, Pharma & Healthcare industry. It covers Europe market data and forecasts. It is priced starting at USD 2,700.00 for Single User License (PDF) which allows one person to use this report.

Please read the description and table of contents of this research report given below to check whether it meets your research requirements. If not, then please do not hesitate to contact us using "Report Enquiry" form given below. We can customize this research report or suggest a new fully customized market research report to meet your research goals and data requirements.

Europe Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity

Printer version

Send by email

Publication ID:听

GRM0321039

Publication Date:听

March 30, 2021

笔补驳别蝉:听

131

笔耻产濒颈蝉丑别谤:听

Grace 麻豆原创 Data

颁辞耻苍迟谤颈别蝉:听

Europe

USD 2,700.00

Pay By Invoice

If you wish to purchase this report using bank/wire transfer against an invoice, please fill your details using request invoice form given below.

Globally Trusted Brand

We help executives from firms听to Start-ups听with their market research needs thus听we can help you too.听

Secure Checkout

You can shop confidently as your online payments are processed using PCI DSS compliant secure payment gateways on our website.

Frequently Asked Questions

If you have any pre-sales听questions related to this report please let us know using the "Report Enquiry" form below. This will help us provide you听with answers听so that you can purchase with confidence. If you wish to read about frequently asked questions by our customers please visit our .

Tabs

Description

Europe pharmaceutical manufacturing industry accounted for $84.31 billion in 2020 and will grow by 12.9% annually over 2020-2030 driven by increased drug approvals, increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic.
Highlighted with 36 tables and 64 figures, this 131-page report 鈥淓urope Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Europe pharmaceutical manufacturing industry and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� Industry Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & Industry Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Europe industry is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe pharmaceutical manufacturing industry in every aspect of the classification from perspectives of Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country.

Based on Formulation, the Europe industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
鈥� Tablets
鈥� Capsules
鈥� Injectable
鈥� Sprays
鈥� Suspensions
鈥� Powders
鈥� Other Formulations

Based on Route of Administration, the Europe industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
鈥� Oral Medicine
鈥� Topical Medicine
鈥� Parenteral Medicine
鈥� Inhalations
鈥� Other Routes of Administration

Based on Age Group, the Europe industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
鈥� Children & Adolescents
鈥� Adults
鈥� Geriatric

Based on Therapeutic Application, the Europe industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
鈥� Cardiovascular Diseases
鈥� Pain
鈥� Diabetes
鈥� Cancer
鈥� Respiratory Diseases
鈥� Neurological Diseases
鈥� Orthopedics
鈥� Other Applications

Based on Drug Type, the Europe industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
鈥� Branded Prescription Drugs
鈥� Generic Prescription Drugs
鈥� OTC Drugs

Based on Distribution Channels, the Europe industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
鈥� Retail Channels
鈥� Non-retail Channels

Based on Manufacturing Facility, the Europe industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section.
鈥� In-house Facility
鈥� Outsourced Facility

Geographically, the following national/local markets are fully investigated:
鈥� Germany
鈥� UK
鈥� France
鈥� Spain
鈥� Italy
鈥� Russia
鈥� Rest of Europe (further segmented into Netherlands, Switzerland, Turkey, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual production value are available for 2017-2027. The breakdown of key national industry by Formulation, Route of Administration, and Drug Type over the forecast years is also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including industry leaders and important emerging players.
Specifically, potential risks associated with investing in Europe pharmaceutical manufacturing industry are assayed quantitatively and qualitatively through GMD鈥檚 Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
Aenova Group
Amgen
AstraZeneca
Catalent Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences
GlaxoSmithKline plc
Johnson & Johnson
Lonza Group
Lupin
Merck & Co., Inc.
Novartis AG
Novo Nordisk
Pfizer, Inc.
Roche
Sanofi SA
Takeda
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

Table of Contents
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Industry Research Methodology 11
1.2.2 Industry Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Industry Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Industry Overview and Dynamics 20
2.1 Industry Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Industry 24
2.2 Major Growth Drivers 26
2.3 Industry Restraints and Challenges 29
2.4 Emerging Opportunities and Industry Trends 32
2.5 Porter鈥檚 Fiver Forces Analysis 36
3 Segmentation of Europe Industry by Formulation 40
3.1 Industry Overview by Formulation 40
3.2 Tablets 42
3.3 Capsules 43
3.4 Injectable 44
3.5 Sprays 45
3.6 Suspensions 46
3.7 Powders 47
3.8 Other Formulations 48
4 Segmentation of Europe Industry by Route of Administration 49
4.1 Industry Overview by Route of Administration 49
4.2 Oral Medicine 51
4.3 Topical Medicine 52
4.4 Parenteral Medicine 53
4.5 Inhalations 54
4.6 Other Routes of Administration 55
5 Segmentation of Europe Industry by Age Group 56
5.1 Industry Overview by Age Group 56
5.2 Children & Adolescents 58
5.3 Adults 59
5.4 Geriatric 60
6 Segmentation of Europe Industry by Therapeutic Application 61
6.1 Industry Overview by Therapeutic Application 61
6.2 Cardiovascular Diseases 63
6.3 Pain 64
6.4 Diabetes 65
6.5 Cancer 66
6.6 Respiratory Diseases 67
6.7 Neurological Diseases 68
6.8 Orthopedics 69
6.9 Other Applications 70
7 Segmentation of Europe Industry by Drug Type 71
7.1 Industry Overview by Drug Type 71
7.2 Branded Prescription Drugs 73
7.3 Generic Prescription Drugs 74
7.4 OTC Drugs 75
8 Segmentation of Europe Industry by Distribution Channels 76
8.1 Industry Overview by Distribution Channels 76
8.2 Retail Channels 78
8.3 Non-retail Channels 79
9 Segmentation of Europe Industry by Manufacturing Facility 80
9.1 Industry Overview by Manufacturing Facility 80
9.2 In-house Facility 82
9.3 Outsourced Facility 83
10 European Industry 2020-2027 by Country 84
10.1 Overview of European Industry 84
10.2 UK 87
10.3 France 89
10.4 Germany 91
10.5 Spain 93
10.6 Italy 95
10.7 Russia 97
10.8 Rest of European Industry 99
11 Competitive Landscape 101
11.1 Overview of Key Vendors 101
11.2 New Product Launch, Partnership, Investment, and M&A 104
11.3 Company Profiles 105
Abbott Laboratories 105
Aenova Group 107
Amgen 108
AstraZeneca 109
Catalent Inc. 110
Eli Lilly and Company 111
F. Hoffmann-La Roche Ltd. 112
Gilead Sciences 113
GlaxoSmithKline plc 114
Johnson & Johnson 115
Lonza Group 116
Lupin 117
Merck & Co., Inc. 118
Novartis AG 119
Novo Nordisk 120
Pfizer, Inc. 121
Roche 122
Sanofi SA 123
Takeda 124
12 Investing in Europe Industry: Risk Assessment and Management 125
12.1 Risk Evaluation of Europe Industry 125
12.2 Critical Success Factors (CSFs) 128
Related Reports and Products 131

Companies Covered

Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
Aenova Group
Amgen
AstraZeneca
Catalent Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences
GlaxoSmithKline plc
Johnson & Johnson
Lonza Group
Lupin
Merck & Co., Inc.
Novartis AG
Novo Nordisk
Pfizer, Inc.
Roche
Sanofi SA
Takeda

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Enquiry / Request Invoice

Report Inquiry

Do you have more questions related to this market research report after going through the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

First Name *

Last Name *

Company *

Email Address *

Phone (Including International Code) *

Report Title *

Do you need invoice for purchasing this report? *

Address 1

Address 2

City/Town

Postal/Zip Code

Country

License Type

Your Inquiry *

CAPTCHA

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Pharmaceutical Manufacturing

Pharma & Healthcare

*Please note that the report cover image shown above is for representation purpose only. Actual report cover may vary.

听

Related 麻豆原创 Research Reports

Publication	Price
Global Hirudin-based Drugs 麻豆原创 Growth (Status and Outlook) 2025-2031 According to this study, the global Hirudin-based Drugs market size will reach US$ 5056 million by 2031. Hirudin is a natural anticoagulant protein initially extracted from leeches, known for its powerful blood-thinning properties. It works by directly binding to thrombin, inhibiting its activity, and thus effectively preventing blood coagulation. Over time, the production of hirudin has transitioned from natural extraction to recombinant DNA technology, significantly improving production efficiency, safety, and product consistency. Common hirudin-based products include Lepirudin (Refludan) and Desirudin (Iprivask), which are primarily used in the treatment and prevention of thrombotic diseases such as deep vein thrombosis (DVT), pulmonary embolism (PE), and thrombus-related cardiovascular conditions. Hirudin products are particularly suitable for patients who cannot use traditional anticoagulants, such as those with heparin-induced thrombocytopenia (HIT). These products have...Read more	USD 3,660.00
Global Chinese Medicine Injection for Respiratory System 麻豆原创 Growth 2025-2031 The global Chinese Medicine Injection for Respiratory System market size is predicted to grow from US$ 1316 million in 2025 to US$ 1663 million in 2031; it is expected to grow at a CAGR of 4.0% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Chinese Medicine Injections for the Respiratory System are injectable formulations developed from traditional herbal remedies aimed at treating respiratory conditions such as infections, cough, asthma, and pulmonary inflammation. These injections typically offer functions like clearing heat and toxins, relieving cough and asthma, and resolving phlegm and dampness. They are often used as adjunctive therapies in acute respiratory cases, particularly within integrated traditional and modern medical approaches. While...Read more	USD 3,660.00
Global CXO Services 麻豆原创 Growth (Status and Outlook) 2025-2031 According to this study, the global CXO Services market size will reach US$ 161583 million by 2031. CXO Services refer to a broad category of outsourced services provided to pharmaceutical, biotechnology, and life sciences companies to support the development, manufacturing, and commercialization of drugs and therapeutics. The term "CXO" collectively represents contract-based services, in this report, CXO include CRO and CDMO. United States market for CXO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for CXO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for CXO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key CXO Services players cover Lonza, Catalent, Samsung Biologics, FUJIFILM...Read more	USD 3,660.00
Global Blood Lipid Control Products 麻豆原创 Growth 2025-2031 The global Blood Lipid Control Products market size is predicted to grow from US$ 151 million in 2025 to US$ 183 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Blood lipid control products are standard reference materials used for quality control of blood lipid items (such as cholesterol and triglycerides) in clinical tests. They are usually made from processed serum and have clear target values 鈥嬧€媋nd stability. They can be used to monitor and evaluate the performance of testing instruments and reagents to ensure the accuracy and consistency of test results. They are an indispensable and important part of the laboratory quality management system. United States market for Blood Lipid...Read more	USD 3,660.00
Global Chinese Medicine Injection for Nervous Diseases 麻豆原创 Growth 2025-2031 The global Chinese Medicine Injection for Nervous Diseases market size is predicted to grow from US$ 2008 million in 2025 to US$ 2467 million in 2031; it is expected to grow at a CAGR of 3.5% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Chinese medicine injections for nervous system diseases are formulations that combine traditional Chinese medicine principles with modern pharmaceutical technology, primarily used to treat cerebrovascular diseases, neurodegenerative disorders, and neuropathic pain. Administered intravenously or intramuscularly, these injections bypass the gastrointestinal tract, enhancing bioavailability and providing rapid therapeutic effects, making them suitable for acute and severe cases. Common examples include XingNaoJing...Read more	USD 3,660.00

Clients Who Trust Us

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At 麻豆原创 we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

麻豆原创 Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

Latest Blog Posts

Stay Connected

Disclaimer: 麻豆原创 has no affiliation to, and is not associated with any other website(s) or organization(s). We offer syndicated research reports (like country analysis, SWOT analysis, competitive intelligence, industry reports, company reports and market analysis & trends reports) and custom market research from our website 麻豆原创ResearchReports.com only.

If you are looking for a market research solution for your research requirements, please begin your search using the search box on top of this page or use our chat system to speak to our market research consultants or directly write to us.

麻豆原创